Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Standard shipping typically takes 2-5 business days within the continental USA
Appel, K., et al
GLP-1 medications can support weight reduction, but the rate and magnitude of loss must be sustainable and compatible with fitness testing schedules and PT demands
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 18 Long-Term Efficacy Trajectories of GLP-1 Receptor Agonists: A Systematic Review and Network Meta-Analysis Authors Li Z , Han Z, Sun R, Xuan X, Huang C Received 16 May 2025 Accepted for publication 19 August 2025 Published 23 September 2025 Volume 2025:18 Pages 36113624 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Halis Akturk Zixuan Li, 1, * Zhoubo Han, 1, * Rong Sun, 2 Xiuping Xuan, 3 Chenghu Huang 1 1 Department of Endocrinology, Bishan Hospital of Chongqing Medical University, Bishan, Chongqing, 402760, Peoples Republic of China
US$ 26.20
US$ 29.36
US$ 20.14
